JPWO2020239568A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2020239568A5
JPWO2020239568A5 JP2021569359A JP2021569359A JPWO2020239568A5 JP WO2020239568 A5 JPWO2020239568 A5 JP WO2020239568A5 JP 2021569359 A JP2021569359 A JP 2021569359A JP 2021569359 A JP2021569359 A JP 2021569359A JP WO2020239568 A5 JPWO2020239568 A5 JP WO2020239568A5
Authority
JP
Japan
Prior art keywords
etoh
methanesulfonylphenoxy
fluoro
propyl
ethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021569359A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022533433A (ja
JP7623958B2 (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2020/064046 external-priority patent/WO2020239568A1/en
Publication of JP2022533433A publication Critical patent/JP2022533433A/ja
Publication of JPWO2020239568A5 publication Critical patent/JPWO2020239568A5/ja
Application granted granted Critical
Publication of JP7623958B2 publication Critical patent/JP7623958B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021569359A 2019-05-24 2020-05-20 [2-(3-フルオロ-5-メタンスルホニルフェノキシ)エチル](プロピル)アミンの薬学的に許容される塩、およびその使用 Active JP7623958B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP19176514.8 2019-05-24
EP19176514 2019-05-24
EP20166361 2020-03-27
EP20166361.4 2020-03-27
PCT/EP2020/064046 WO2020239568A1 (en) 2019-05-24 2020-05-20 Pharmaceutically acceptable salts of [2-(3-fluoro-5-methane-sulfonylphenoxy)ethyl](propyl)amine and uses thereof

Publications (3)

Publication Number Publication Date
JP2022533433A JP2022533433A (ja) 2022-07-22
JPWO2020239568A5 true JPWO2020239568A5 (enrdf_load_stackoverflow) 2023-05-29
JP7623958B2 JP7623958B2 (ja) 2025-01-29

Family

ID=70682855

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021569359A Active JP7623958B2 (ja) 2019-05-24 2020-05-20 [2-(3-フルオロ-5-メタンスルホニルフェノキシ)エチル](プロピル)アミンの薬学的に許容される塩、およびその使用

Country Status (21)

Country Link
US (2) US12275694B2 (enrdf_load_stackoverflow)
EP (2) EP3976581B1 (enrdf_load_stackoverflow)
JP (1) JP7623958B2 (enrdf_load_stackoverflow)
KR (1) KR20220011638A (enrdf_load_stackoverflow)
CN (1) CN113853369B (enrdf_load_stackoverflow)
AU (1) AU2020286003B2 (enrdf_load_stackoverflow)
BR (1) BR112021023563A2 (enrdf_load_stackoverflow)
CA (1) CA3140805A1 (enrdf_load_stackoverflow)
CL (1) CL2021003115A1 (enrdf_load_stackoverflow)
CO (1) CO2021016556A2 (enrdf_load_stackoverflow)
DK (1) DK3976581T3 (enrdf_load_stackoverflow)
ES (1) ES2970361T3 (enrdf_load_stackoverflow)
FI (1) FI3976581T3 (enrdf_load_stackoverflow)
IL (1) IL288271B2 (enrdf_load_stackoverflow)
JO (1) JOP20210312A1 (enrdf_load_stackoverflow)
MX (1) MX2021014271A (enrdf_load_stackoverflow)
PH (1) PH12021552844A1 (enrdf_load_stackoverflow)
PL (1) PL3976581T3 (enrdf_load_stackoverflow)
PT (1) PT3976581T (enrdf_load_stackoverflow)
SG (1) SG11202112165QA (enrdf_load_stackoverflow)
WO (1) WO2020239568A1 (enrdf_load_stackoverflow)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20220011638A (ko) 2019-05-24 2022-01-28 인터그레이티브 리서치 래버러토리즈 스웨덴 에이비 [2-(3-플루오로-5-메탄-술포닐페녹시)에틸](프로필)아민의 제약상 허용되는 염 및 그의 용도
JP2023548429A (ja) * 2020-11-10 2023-11-16 インテグレイティブ・リサーチ・ラボラトリーズ・スウェーデン・アーベー パーキンソン病、特にl-dopa誘発性ジスキネジアのための医薬品に対する感作の予防または軽減における使用のための[2-(3-フルオロ-5-メタンスルホニルフェノキシ)エチル](プロピル)アミン(メスドペタム)
EP4577201A1 (en) * 2022-08-24 2025-07-02 Alkem Laboratories Limited Mesdopetam compositions
IL319769A (en) 2022-09-21 2025-05-01 Assia Chem Ind Ltd Solid forms of mesodoptam and its salts
GB202312055D0 (en) * 2023-08-07 2023-09-20 Ipsen Biopharm Ltd Pharmaceutical compositions

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS51123821A (en) 1975-04-18 1976-10-28 Nippon Kayaku Co Ltd An algicide and protective agent
US4128574A (en) * 1976-10-04 1978-12-05 General Electric Company Method for making organic polycarboxylic acids
GB8823405D0 (en) 1988-10-05 1988-11-09 Erba Carlo Spa Aryloxy-arythio-heteraryloxy-heteroarylthio-alkenylene derivatives of amines
EP1123933A1 (en) 1994-10-14 2001-08-16 MERCK PATENT GmbH 2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]chromane as CNS active agent
SE9904723D0 (sv) * 1999-12-22 1999-12-22 Carlsson A Research Ab New modulators of dopamine neurotransmission II
DOP2001000189A (es) 2000-06-30 2002-03-30 Pfizer Prod Inc Benzofenonas y sulfonas como inhibidores de la captación de glicina
JP2006193494A (ja) 2005-01-17 2006-07-27 Dainippon Ink & Chem Inc 4級アンモニウム系化合物を有効成分とする心臓疾患治療剤
US20100069346A1 (en) 2005-06-23 2010-03-18 Sara Holmqvist New Azetidine Derivatives as Neurokinin Receptor Antagonists for the Treatment of Gastrointestinal Diseases
JP5210637B2 (ja) 2005-11-29 2013-06-12 キッセイ薬品工業株式会社 新規なカテコール誘導体、それを含有する医薬組成物およびそれらの用途
WO2007072041A1 (en) 2005-12-23 2007-06-28 Astex Therapeutics Limited Therapeutic compounds
JP2009526844A (ja) * 2006-02-15 2009-07-23 株式会社エムズサイエンス ピペラジン誘導体
CA2687721A1 (en) * 2007-06-08 2008-12-18 Arena Pharmaceuticals, Inc. Crystalline forms of (r)-1-{2-[4'-(3-methoxy-propane-1-sulfonyl)-biphenyl-4-yl]-ethyl}-2-methyl-pyrrolidine, and compositions, and methods related thereto
TW200932225A (en) * 2007-12-14 2009-08-01 Lundbeck & Co As H 4-[2,3-difluoro-6-(2-fluoro-4-methyl-phenylsulfanyl)-phenyl]-piperidine
EP2271634B1 (en) 2008-04-29 2014-02-12 Integrative Research Laboratories Sweden AB Modulators of dopamine neurotransmission
US20110105462A1 (en) 2008-04-29 2011-05-05 Nsab, Filial Af Neurosearch Sweden Ab, Sverige Modulators of dopamine neurotransmission
JP5548853B2 (ja) 2008-04-29 2014-07-16 インテグレイティブ・リサーチ・ラボラトリーズ・スウェーデン・アーベー ドーパミン神経伝達のモジュレーター
WO2012143337A1 (en) 2011-04-19 2012-10-26 Neurosearch A/S Novel modulators of cortical dopaminergic- and nmda-receptor-mediated glutamatergic neurotransmission
US9796673B2 (en) 2014-12-22 2017-10-24 Teva Pharmaceuticals International Gmbh L-tartrate salt of pridopidine
RU2018131500A (ru) 2016-02-08 2020-03-10 Мерк Патент Гмбх Кристаллические модификации гидрохлорида n-(4,5-бисметансульфонил-2-метилбензоил)гуанидина и солей n-(4,5-бисметансульфонил-2-метилбензоил)гуанидина
CN110621659B (zh) 2017-05-19 2023-02-28 综合研究实验室瑞典股份公司 (+)-3-(2,3-二氟苯基)-3-甲氧基吡咯烷或其药学上可接受的盐、其制备方法及其用途
BR112020002227A2 (pt) * 2017-08-07 2020-07-28 Suven Life Sciences Limited compostos de fluoropiperidina como antagonistas do receptor 5-ht6 puro
WO2020110128A1 (en) 2018-11-29 2020-06-04 Prilenia Neurotherapeutics Ltd. Combination of pridopidine and an additional therapeutic agent for treating drug induced dyskinesia
KR20220011638A (ko) 2019-05-24 2022-01-28 인터그레이티브 리서치 래버러토리즈 스웨덴 에이비 [2-(3-플루오로-5-메탄-술포닐페녹시)에틸](프로필)아민의 제약상 허용되는 염 및 그의 용도

Similar Documents

Publication Publication Date Title
SU522800A3 (ru) Способ получени производных пиразоло (1,5-а) пиримидина
JP2012500819A5 (enrdf_load_stackoverflow)
JP2009531313A5 (enrdf_load_stackoverflow)
CN116715663A (zh) 一种非奈利酮及其中间体的制备方法
JP2023154056A (ja) エパルレスタットを調製する方法
JPWO2020239568A5 (enrdf_load_stackoverflow)
JP7379470B2 (ja) レンバチニブの調製方法
JP2010510253A5 (enrdf_load_stackoverflow)
TW212181B (enrdf_load_stackoverflow)
JPS5821658B2 (ja) エンキセイオキサジンセンリヨウノセイホウ
JP2020533284A (ja) ガドブトロール中間体及びこれを用いたガドブトロールの製造方法
CN117466867B (zh) 一种合成沃诺拉赞的新工艺及其应用
JP2010502682A5 (enrdf_load_stackoverflow)
JP6228210B2 (ja) フルボキサミン遊離塩基の精製方法およびそれを用いた高純度フルボキサミンマレイン酸塩の製造方法
JP2009503034A (ja) 7H−ピロロ[2,3−d]ピリミジン誘導体の製造方法
JP5757665B2 (ja) イマチニブ塩基を調製する新規な方法
JP2008101014A (ja) 2−オキシインドール誘導体の製造法
CN101717370A (zh) 一种制备2-正丙基-4-甲基-6-(1-甲基苯并咪唑-2-基)苯并咪唑的新方法
JP6284942B2 (ja) 4−アミノ−2,5−ジメトキシピリミジンから2−アミノ−5,8−ジメトキシ[1,2,4]トリアゾロ[1,5−c]ピリミジンを調製するための改善された方法
CN104230739B (zh) 用均苯三甲酸生产n, nˊ,nˊˊ-三环己基-1,3,5-苯酰胺的工艺
CN114394941A (zh) 一种2,4-二氨基-6-氯嘧啶的制备方法
JP7683005B2 (ja) Pi3k阻害剤としての化合物の製造方法及びその製造のための中間体化合物
CN105294697B (zh) 2-氨基-5,8-二甲氧基[1,2,4]三唑并[1,5-c]嘧啶的合成方法
CN119409681A (zh) 一种盐酸丁螺环酮的制备方法
JP4078328B2 (ja) 2−オキシインドール誘導体の製造法